TVTX as of Oct 31 · 20:08 ET

TVTXNasdaqPharmaceutical Preparations

Travere Therapeutics, Inc. · Brief

Next report

1 day

Nov 2 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±6.7%implied · report alone

47.0153.77

straddle ±10.0%

spot 50.39exp Nov 20ATM strike 50ATM straddle 5.95IV 62%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

1 of 8≥ implied

avg implied: ±12.6%
avg realized: ±7.6%

Jan 13 '25±11.2%▲+2.76%×0.25

Feb 20 '25±8.4%▼−6.79%×0.80

Aug 6 '25±9.6%▼−1.91%×0.20

Oct 30 '25±10.3%▲+18.58%×1.81

Jan 12 '26±31.8%▼−14.63%×0.46

Feb 19 '26±9.4%▲+3.72%×0.40

Q1 FY26±6.8%▼−0.24%×0.04

Q2 FY26±13.4%▲+12.03%×0.90

quarterimplied−35%0+35%realized×

Q2 FY26±13.4%▲+12.03%×0.90

Q1 FY26±6.8%▼−0.24%×0.04

Feb '26±9.4%▲+3.72%×0.40

Jan '26±31.8%▼−14.63%×0.46

Oct '25±10.3%▲+18.58%×1.81

Aug '25±9.6%▼−1.91%×0.20

2 older reports

Feb '25±8.4%▼−6.79%×0.80

Jan '25±11.2%▲+2.76%×0.25

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 2 report · est.

Bull2 of 3

317managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+0.94%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

9 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

4tracked funds holding TVTXN-PORT · Aug 31 '26

AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

TVTX report session

Suppliers 1

LGNDLigand Pharmaceuticals×0.20

× = co-movement · max 499dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 30impliedImplied move: ±9.9% into Nov 2 earnings (Oct 30 close).Source

Oct 15impliedImplied move: ±11.2% into Oct 29 earnings (Oct 15 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.